Clinical trials: Moducare
Low-grade Cervical Intraepithelial Neoplasia, Moducare
MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)
MODUCIN-1 (MODUcare for CIN1) is a prospective, single center, open-label, randomized trial that its purpose is to compare MODUCARE versus Wait-and-See Approach for the regression rate of histologically proven low-grade Cervical…
- Trial name
- MODUCIN1 (NCT07379905)
- Testing
- MODUCARE
- Volunteers
- 182 people, healthy volunteers welcome
- Sponsor
- Aristotle University Of Thessaloniki